| scholarly article | Q13442814 |
| P2093 | author name string | Smith R | |
| Peters G | |||
| Fisher C | |||
| Dickson C | |||
| Barnes D | |||
| Fantl V | |||
| Bartek J | |||
| Gillett C | |||
| P4510 | describes a project that uses | immunohistochemistry | Q899285 |
| P433 | issue | 7 | |
| P921 | main subject | breast cancer | Q128581 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 1812-1817 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining | |
| P478 | volume | 54 |
| Q36134760 | A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer |
| Q38582323 | A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer |
| Q85768358 | A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy |
| Q24314746 | A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation |
| Q33997396 | A specific role for cyclin D1 in mammary gland development |
| Q37580471 | Aberrant expression of cyclin D1 in cancer |
| Q36422016 | Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients |
| Q33918764 | Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers |
| Q34026139 | Acetonic extract of Buxus sempervirens induces cell cycle arrest, apoptosis and autophagy in breast cancer cells |
| Q40848979 | Amplification and overexpression of the cyclin D1 gene in head and neck squamous cell carcinoma |
| Q35763656 | Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast |
| Q21195209 | Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin |
| Q41613251 | Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells |
| Q93089128 | Are all cyclin-dependent kinases 4/6 inhibitors created equal? |
| Q58552901 | Association between G870A (rs9344) polymorphism and cancer risk in Indian population: Meta-analysis and Trial Sequential Analysis |
| Q39076047 | Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis |
| Q64087952 | Association of FOSL1 copy number alteration and triple negative breast tumors |
| Q42316312 | Association of ICAM-1, VCAM-1, CYCLIN D1 and Cathepsin D with Clinicopathological Parameters in Breast Carcinoma; an Immunohistochemical Study |
| Q34064538 | BRCA1 transcriptionally regulates genes involved in breast tumorigenesis |
| Q34543461 | Beta-catenin and Tcfs in mammary development and cancer |
| Q35679187 | Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression |
| Q27852008 | Biomarkers for the clinical management of breast cancer: International perspective |
| Q34101905 | Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells |
| Q35624792 | Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles |
| Q34036076 | CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. |
| Q57107726 | CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion |
| Q39601717 | Cell Cycle Protein Cyclin Y Is Associated With Human Non–Small-Cell Lung Cancer Proliferation and Tumorigenesis |
| Q34076478 | Cell cycle checkpoints and their inactivation in human cancer |
| Q33588357 | Cell cycle regulators and their abnormalities in breast cancer |
| Q40524872 | Chromosome 11q13 markers and D-type cyclins in breast cancer |
| Q36431072 | Classical gene amplifications in human breast cancer are not associated with distant solid metastases |
| Q92029556 | Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China |
| Q36238230 | Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review |
| Q37030174 | Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study |
| Q34579889 | Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells |
| Q36634397 | Correlation between cyclin D1 expression and standard clinicopathological variables in invasive breast cancer in Eastern India |
| Q37640655 | Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer |
| Q58585562 | Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis |
| Q24803368 | Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients |
| Q24644847 | Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4† |
| Q33840107 | Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression |
| Q40794379 | Cyclin D1 and human neoplasia |
| Q24796232 | Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models |
| Q35764646 | Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. |
| Q36622503 | Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. |
| Q36641208 | Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer |
| Q36294947 | Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma |
| Q35788347 | Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck |
| Q38834030 | Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation |
| Q38471118 | Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder |
| Q41578764 | Cyclin D1/PRAD1 as a central target in oncogenesis |
| Q34775678 | Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome |
| Q35745372 | Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases |
| Q34582060 | Cyclin T1 overexpression induces malignant transformation and tumor growth |
| Q51363759 | Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma |
| Q73973164 | Cyclins and breast cancer |
| Q79922062 | Cyclins and breast cancer |
| Q51738323 | Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells |
| Q36206691 | Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. |
| Q33566343 | Disrupting the Rb-Raf-1 interaction: a potential therapeutic target for cancer |
| Q36160923 | Dissecting the roles of beta-catenin and cyclin D1 during mammary development and neoplasia |
| Q33899840 | E2F activators signal and maintain centrosome amplification in breast cancer cells |
| Q36565534 | E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis |
| Q36621254 | ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells |
| Q39797974 | ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells |
| Q47424104 | ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1. |
| Q34606102 | Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma |
| Q36245589 | Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study |
| Q73662909 | Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer |
| Q47551153 | Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance |
| Q39106448 | Euphol arrests breast cancer cells at the G1 phase through the modulation of cyclin D1, p21 and p27 expression |
| Q56516873 | Evaluation of the Role Played by Cyclin D1 as a Diagnostic and Prognostic Marker in the Progression of Oral Carcinogenesis |
| Q91928964 | Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray |
| Q36641066 | Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells |
| Q24678067 | Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses |
| Q61797237 | Extracts from Sageretia thea reduce cell viability through inducing cyclin D1 proteasomal degradation and HO-1 expression in human colorectal cancer cells |
| Q57793316 | Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer |
| Q41332206 | Frequent amplification of the cyclin E gene in human gastric carcinomas |
| Q27013811 | GSK-3 as potential target for therapeutic intervention in cancer |
| Q35793260 | Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation |
| Q33962744 | Genetic analysis of breast cancer progression |
| Q35146602 | Genetically engineered mice as experimental tools to dissect the critical events in breast cancer |
| Q38502919 | Genome-wide screening of indicator genes for assessing the potential carcinogenic risk of Nanjing city drinking water |
| Q26738987 | Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer |
| Q36184676 | High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers |
| Q90441662 | Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells |
| Q35076272 | Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. |
| Q43851743 | IGF‐1 induces Pin1 expression in promoting cell cycle S‐phase entry |
| Q55026872 | Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. |
| Q38477902 | Immunohistochemistry of cyclin D3 in pulmonary carcinomas |
| Q43701627 | In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53 |
| Q42324488 | Increase of the therapeutic effect on non-small-cell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro |
| Q33919283 | Increased cyclin D1 expression in cancer of the ampulla of Vater: relevance to nuclear beta catenin accumulation and k-ras gene mutation |
| Q53403192 | Increased expression of cyclin D1, cyclin E and p21(Cip1) associated with decreased expression of p27(Kip1) in chemically induced rat mammary carcinogenesis |
| Q36081611 | Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer |
| Q37376213 | Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NFκB2 (p100). |
| Q34122589 | Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element |
| Q36580735 | Integration of progesterone receptor action with rapid signaling events in breast cancer models |
| Q47835152 | Inverse Association Between Cyclin D1 Overexpression and Retinoblastoma Gene Mutation in Thyroid Carcinomas |
| Q34613461 | Key signaling nodes in mammary gland development and cancer: β-catenin |
| Q36473652 | Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma |
| Q34677472 | Lactation defect in mice lacking the helix-loop-helix inhibitor Id2 |
| Q36462357 | Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors |
| Q24595709 | Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1 |
| Q34009230 | Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes |
| Q34813351 | Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice |
| Q33830304 | MUC1 regulates nuclear localization and function of the epidermal growth factor receptor |
| Q36753508 | MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches |
| Q35879924 | MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells |
| Q92512968 | Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice |
| Q33631775 | Minireview: Tipping the balance: ligand-independent activation of steroid receptors |
| Q36772197 | Mitochondrial reactive oxygen species perturb AKT/cyclin D1 cell cycle signaling via oxidative inactivation of PP2A in lowdose irradiated human fibroblasts. |
| Q37485770 | Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis |
| Q92238135 | Modeling the Dynamics of Let-7-Coupled Gene Regulatory Networks Linking Cell Proliferation to Malignant Transformation |
| Q37535523 | Modulation of cyclins, p53 and mitogen-activated protein kinases signaling in breast cancer cell lines by 4-(3,4,5-trimethoxyphenoxy)benzoic acid |
| Q59791901 | Moving Breast Cancer Therapy up a Notch |
| Q35798342 | Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia |
| Q37610084 | Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis |
| Q86277819 | No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample |
| Q24303548 | Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase |
| Q39258788 | Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication |
| Q37470373 | Nuclear cyclin D1: an oncogenic driver in human cancer |
| Q36065105 | Nucleolar GTP-binding Protein-1 (NGP-1) Promotes G1 to S Phase Transition by Activating Cyclin-dependent Kinase Inhibitor p21 Cip1/Waf1. |
| Q36420373 | Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors |
| Q55710176 | Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition. |
| Q35795143 | Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. |
| Q41855173 | Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers |
| Q73630327 | Overexpression of cyclin D1 mRNA in colorectal carcinomas and relationship to clinicopathological features: an in situ hybridization analysis |
| Q21195212 | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro |
| Q59808745 | PIN1 in Cell Cycle Control and Cancer |
| Q34283602 | PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells |
| Q28387216 | Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer |
| Q38946190 | Parkin and mitophagy in cancer. |
| Q36329257 | Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report. |
| Q40486142 | Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. |
| Q24535558 | Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. |
| Q34078491 | Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression |
| Q21285102 | Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis |
| Q35150980 | Prevention of Bronchial Hyperplasia by EGFR Pathway Inhibitors in an Organotypic Culture Model |
| Q77683176 | Prognosis and prediction of response in breast cancer: the current role of the main biological markers |
| Q34086636 | Prognostic biomarkers in ovarian cancer |
| Q36134992 | Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer |
| Q36291799 | Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter |
| Q36644111 | Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays |
| Q37632170 | Progress with palbociclib in breast cancer: latest evidence and clinical considerations |
| Q33859439 | Regulation of Glioblastoma Progression by Cord Blood Stem Cells Is Mediated by Downregulation of Cyclin D1 |
| Q24791043 | Regulation of Id2 expression by CCAAT/enhancer binding protein beta |
| Q33635621 | Regulation of hormonal therapy resistance by cell cycle machinery |
| Q33966444 | Regulation of the functional interaction between cyclin D1 and the estrogen receptor |
| Q36028468 | Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. |
| Q37536936 | Role of cyclin D1 in breast carcinoma |
| Q34452617 | SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. |
| Q89903809 | SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability |
| Q36917747 | Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer |
| Q37071327 | Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis |
| Q34989052 | Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells |
| Q35607385 | Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells |
| Q36798059 | TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization |
| Q34040108 | Tailoring to RB: tumour suppressor status and therapeutic response |
| Q34387697 | Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer |
| Q26827580 | Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors |
| Q33886076 | The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-Catenin |
| Q28592198 | The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation |
| Q55237298 | The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma |
| Q41528803 | The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis |
| Q36186374 | The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis |
| Q37122778 | The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer |
| Q40442663 | The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a review |
| Q64086537 | The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours |
| Q55033417 | The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer. |
| Q24795560 | The prolyl isomerase Pin1 in breast development and cancer |
| Q21245733 | The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention |
| Q78828706 | The relationship of CyclinD1 and estrogen receptor expression in the process of proliferation and metastasis in breast neoplasm |
| Q37505500 | The role of cyclin D1 in response to long-term exposure to ionizing radiation |
| Q36254816 | The role of oncogenes in drug resistance |
| Q41205948 | The role of the cell cycle in genitourinary carcinoma |
| Q38694659 | The role of β-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer |
| Q33959317 | Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia |
| Q33236460 | Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice |
| Q38794109 | Treating cancer with selective CDK4/6 inhibitors |
| Q35639956 | Tumor-suppressive Effects of Psoriasin (S100A7) Are Mediated through the β-Catenin/T Cell Factor 4 Protein Pathway in Estrogen Receptor-positive Breast Cancer Cells |
| Q37296321 | URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway |
| Q64890070 | Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer. |
| Q34789986 | Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis |
| Q37135253 | Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients |
| Q41145371 | Voltage-gated calcium channels: Novel targets for cancer therapy |
| Q33618690 | Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis |
| Q38807957 | Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. |
| Q51392053 | γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16INK4a pathway. |
Search more.